Walter Anthony Szarek - Publications

Affiliations: 
1967 Biochemistry Rutgers University, New Brunswick, NJ, United States 
 1967- Chemistry Queen's University, Kingston, ON, Canada 
Area:
Carbohydrate Research
Website:
http://faculty.chem.queensu.ca/people/faculty/Szarek/

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Brockhausen I, Nair DG, Chen M, Yang X, Allingham JS, Szarek WA, Anastassiades T. Human acetyl-CoA:glucosamine-6-phosphate N-acetyltransferase 1 has a relaxed donor specificity and transfers acyl groups up to four carbons in length. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 1-8. PMID 26935656 DOI: 10.1139/bcb-2015-0115  1
2015 Czuchry D, Desormeaux P, Stuart M, Jarvis DL, Matta KL, Szarek WA, Brockhausen I. Identification and biochemical characterization of a novel α2,3-sialyltransferase WbwA from pathogenic Escherichia coli serotype O104. Journal of Bacteriology. PMID 26391208 DOI: 10.1128/JB.00521-15  1
2015 Wang S, Hao Y, Lam JS, Vlahakis JZ, Szarek WA, Vinnikova A, Veselovsky VV, Brockhausen I. Biosynthesis of the Common Polysaccharide Antigen of Pseudomonas aeruginosa PAO1: Characterization and Role of GDP-D-Rhamnose:GlcNAc/GalNAc-Diphosphate-Lipid α1,3-D-Rhamnosyltransferase WbpZ. Journal of Bacteriology. 197: 2012-9. PMID 25845842 DOI: 10.1128/JB.02590-14  1
2014 Cremers NAJ, Lundvig DMS, van Dalen SCM, Schelbergen RF, van Lent PLEM, Szarek WA, Regan RF, Carels CE, Wagener FADTG. Curcumin-induced heme oxygenase-1 expression prevents H2O2-induced cell death in wild type and heme oxygenase-2 knockout adipose-derived mesenchymal stem cells International Journal of Molecular Sciences. 15: 17974-17999. PMID 25299695 DOI: 10.3390/ijms151017974  1
2014 Gupta A, Lacoste B, Pistell PJ, Pistel PJ, Ingram DK, Hamel E, Alaoui-Jamali MA, Szarek WA, Vlahakis JZ, Jie S, Song W, Schipper HM. Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease. Journal of Neurochemistry. 131: 778-90. PMID 25111043 DOI: 10.1111/jnc.12927  1
2014 Vukomanovic D, Rahman MN, Bilokin Y, Golub AG, Brien JF, Szarek WA, Jia Z, Nakatsu K. In vitro Activation of heme oxygenase-2 by menadione and its analogs. Medical Gas Research. 4: 4. PMID 24533775 DOI: 10.1186/2045-9912-4-4  1
2013 Roman G, Crandall IE, Szarek WA. Synthesis and anti-Plasmodium activity of benzimidazole analogues structurally related to astemizole. Chemmedchem. 8: 1795-804. PMID 24022991 DOI: 10.1002/cmdc.201300172  1
2013 Gao Y, Aryal RP, Ju T, Cummings RD, Gahlay G, Jarvis DL, Matta KL, Vlahakis JZ, Szarek WA, Brockhausen I. Acceptor specificities and selective inhibition of recombinant human Gal- and GlcNAc-transferases that synthesize core structures 1, 2, 3 and 4 of O-glycans. Biochimica Et Biophysica Acta. 1830: 4274-81. PMID 23578692 DOI: 10.1016/j.bbagen.2013.04.001  1
2013 Rahman MN, Vukomanovic D, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds. J R Soc Interface. 10: 20120697. PMID 23097500 DOI: 10.1098/rsif.2012.0697  1
2012 Gao Y, Liu B, Strum S, Schutzbach JS, Druzhinina TN, Utkina NS, Torgov VI, Danilov LL, Veselovsky VV, Vlahakis JZ, Szarek WA, Wang L, Brockhausen I. Biochemical characterization of WbdN, a β1,3-glucosyltransferase involved in O-antigen synthesis in enterohemorrhagic Escherichia coli O157 Glycobiology. 22: 1092-1102. PMID 22556057 DOI: 10.1093/glycob/cws081  1
2012 Rahman MN, Vlahakis JZ, Vukomanovic D, Lee W, Szarek WA, Nakatsu K, Jia Z. A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition. Plos One. 7: e29514. PMID 22276118 DOI: 10.1371/journal.pone.0029514  1
2011 Vukomanovic D, McLaughlin BE, Rahman MN, Szarek WA, Brien JF, Jia Z, Nakatsu K. Selective activation of heme oxygenase-2 by menadione. Canadian Journal of Physiology and Pharmacology. PMID 22039914 DOI: 10.1139/y11-091  1
2011 Xu C, Liu B, Hu B, Han Y, Feng L, Allingham JS, Szarek WA, Wang L, Brockhausen I. Biochemical characterization of UDP-Gal:GlcNAc-pyrophosphate-lipid β-1,4-Galactosyltransferase WfeD, a new enzyme from Shigella boydii type 14 that catalyzes the second step in O-antigen repeating-unit synthesis. Journal of Bacteriology. 193: 449-59. PMID 21057010 DOI: 10.1128/JB.00737-10  1
2011 Vlahakis JZ, Rahman MN, Roman G, Jia Z, Nakatsu K, Szarek WA. Rapid, convenient method for screening imidazole-containing compounds for heme oxygenase inhibition. Journal of Pharmacological and Toxicological Methods. 63: 79-88. PMID 20561893 DOI: 10.1016/j.vascn.2010.05.015  1
2010 Vukomanovic D, McLaughlin B, Rahman MN, Vlahakis JZ, Roman G, Dercho RA, Kinobe RT, Hum M, Brien JF, Jia Z, Szarek WA, Nakatsu K. Recombinant truncated and microsomal heme oxygenase-1 and -2: differential sensitivity to inhibitors. Canadian Journal of Physiology and Pharmacology. 88: 480-6. PMID 20555417 DOI: 10.1139/y10-004  1
2010 Hum M, McLaughlin BE, Roman G, Vlahakis JZ, Szarek WA, Nakatsu K. The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1/2 and human cytochromes P450 3A4 and 2D6. The Journal of Pharmacology and Experimental Therapeutics. 334: 981-7. PMID 20501634 DOI: 10.1124/jpet.110.168492  1
2010 Roman G, Rahman MN, Vukomanovic D, Jia Z, Nakatsu K, Szarek WA. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone. Chemical Biology & Drug Design. 75: 68-90. PMID 19954435 DOI: 10.1111/j.1747-0285.2009.00909.x  1
2010 Rahman MN, Vlahakis JZ, Roman G, Vukomanovic D, Szarek WA, Nakatsu K, Jia Z. Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitors. Journal of Inorganic Biochemistry. 104: 324-30. PMID 19917515 DOI: 10.1016/j.jinorgbio.2009.10.011  1
2009 Alaoui-Jamali MA, Bismar TA, Gupta A, Szarek WA, Su J, Song W, Xu Y, Xu B, Liu G, Vlahakis JZ, Roman G, Jiao J, Schipper HM. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Research. 69: 8017-24. PMID 19808972 DOI: 10.1158/0008-5472.CAN-09-0419  1
2009 Rahman MN, Vlahakis JZ, Vukomanovic D, Szarek WA, Nakatsu K, Jia Z. X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode. Journal of Medicinal Chemistry. 52: 4946-50. PMID 19601578 DOI: 10.1021/jm900434f  1
2009 Vlahakis JZ, Hum M, Rahman MN, Jia Z, Nakatsu K, Szarek WA. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring. Bioorganic & Medicinal Chemistry. 17: 2461-75. PMID 19268600 DOI: 10.1016/j.bmc.2009.01.078  1
2008 Rahman MN, Vlahakis JZ, Szarek WA, Nakatsu K, Jia Z. X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors. Journal of Medicinal Chemistry. 51: 5943-52. PMID 18798608 DOI: 10.1021/jm800505m  1
2008 Brockhausen I, Riley JG, Joynt M, Yang X, Szarek WA. Acceptor substrate specificity of UDP-Gal: GlcNAc-R beta1,3-galactosyltransferase (WbbD) from Escherichia coli O7:K1. Glycoconjugate Journal. 25: 663-73. PMID 18536883 DOI: 10.1007/s10719-008-9127-7  1
2007 Hull RL, Zraika S, Udayasankar J, Kisilevsky R, Szarek WA, Wight TN, Kahn SE. Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro. American Journal of Physiology. Cell Physiology. 293: C1586-93. PMID 17804609 DOI: 10.1152/ajpcell.00208.2007  0.68
2007 Kisilevsky R, Ancsin JB, Szarek WA, Petanceska S. Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 14: 21-32. PMID 17453622 DOI: 10.1080/13506120601116419  0.68
2007 Roman G, Riley JG, Vlahakis JZ, Kinobe RT, Brien JF, Nakatsu K, Szarek WA. Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring. Bioorganic & Medicinal Chemistry. 15: 3225-34. PMID 17339115 DOI: 10.1016/j.bmc.2007.02.034  1
2007 Crandall IE, Szarek WA, Vlahakis JZ, Xu Y, Vohra R, Sui J, Kisilevsky R. Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy. Biochemical Pharmacology. 73: 632-42. PMID 17166484 DOI: 10.1016/j.bcp.2006.10.030  0.68
2007 Gervais F, Paquette J, Morissette C, Krzywkowski P, Yu M, Azzi M, Lacombe D, Kong X, Aman A, Laurin J, Szarek WA, Tremblay P. Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiology of Aging. 28: 537-47. PMID 16675063 DOI: 10.1016/j.neurobiolaging.2006.02.015  1
2006 Brockhausen I, Szarek WA, Riley JG, Vlahakis JZ. Assay for a galactosyltransferase involved in the assembly of the O7-antigen repeat unit of Escherichia coli. Methods in Molecular Biology (Clifton, N.J.). 347: 253-64. PMID 17072015 DOI: 10.1385/1-59745-167-3:253  1
2006 Brockhausen I, Benn M, Bhat S, Marone S, Riley JG, Montoya-Peleaz P, Vlahakis JZ, Paulsen H, Schutzbach JS, Szarek WA. UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme. Glycoconjugate Journal. 23: 525-41. PMID 17006644 DOI: 10.1007/s10719-006-7153-x  1
2006 Vlahakis JZ, Kinobe RT, Bowers RJ, Brien JF, Nakatsu K, Szarek WA. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors. Journal of Medicinal Chemistry. 49: 4437-41. PMID 16821802 DOI: 10.1021/jm0511435  1
2005 Berkin A, Szarek WA, Kisilevsky R. Biological evaluation of a series of 2-acetamido-2-deoxy-D-glucose analogs towards cellular glycosaminoglycan and protein synthesis in vitro. Glycoconjugate Journal. 22: 443-51. PMID 16311889 DOI: 10.1007/s10719-005-5060-1  0.68
2005 Vlahakis JZ, Kinobe RT, Bowers RJ, Brien JF, Nakatsu K, Szarek WA. Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15: 1457-61. PMID 15713406 DOI: 10.1016/j.bmcl.2004.12.075  1
2005 Montoya-Peleaz PJ, Riley JG, Szarek WA, Valvano MA, Schutzbach JS, Brockhausen I. Identification of a UDP-Gal: GlcNAc-R galactosyltransferase activity in Escherichia coli VW187. Bioorganic & Medicinal Chemistry Letters. 15: 1205-11. PMID 15686943 DOI: 10.1016/j.bmcl.2004.11.077  1
2005 Riley JG, Menggad M, Montoya-Peleaz PJ, Szarek WA, Marolda CL, Valvano MA, Schutzbach JS, Brockhausen I. The wbbD gene of E. coli strain VW187 (O7:K1) encodes a UDP-Gal: GlcNAc{alpha}-pyrophosphate-R {beta}1,3-galactosyltransferase involved in the biosynthesis of O7-specific lipopolysaccharide. Glycobiology. 15: 605-13. PMID 15625181 DOI: 10.1093/glycob/cwi038  1
2004 Elimova E, Kisilevsky R, Szarek WA, Ancsin JB. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1749-51. PMID 15345688 DOI: 10.1096/fj.03-1436fje  0.68
2004 Kisilevsky R, Szarek WA, Ancsin J, Vohra R, Li Z, Marone S. Novel glycosaminoglycan precursors as antiamyloid agents: Part IV. Journal of Molecular Neuroscience : Mn. 24: 167-72. PMID 15314266 DOI: 10.1385/JMN:24:1:167  0.68
2004 Kisilevsky R, Szarek WA, Ancsin JB, Elimova E, Marone S, Bhat S, Berkin A. Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses. The American Journal of Pathology. 164: 2127-37. PMID 15161647  0.68
2003 Kisilevsky R, Szarek WA, Ancsin J, Bhat S, Li Z, Marone S. Novel glycosaminoglycan precursors as anti-amyloid agents, part III. Journal of Molecular Neuroscience : Mn. 20: 291-7. PMID 14501011 DOI: 10.1385/JMN:20:3:291  0.68
2002 Kisilevsky R, Szarek WA. Novel glycosaminoglycan precursors as anti-amyloid agents part II. Journal of Molecular Neuroscience : Mn. 19: 45-50. PMID 12212792 DOI: 10.1007/s12031-002-0009-3  0.68
2002 Kisilevsky R, Crandall I, Szarek WA, Bhat S, Tan C, Boudreau L, Kain KC. Short-chain aliphatic polysulfonates inhibit the entry of Plasmodium into red blood cells. Antimicrobial Agents and Chemotherapy. 46: 2619-26. PMID 12121942 DOI: 10.1128/AAC.46.8.2619-2626.2002  1
2002 Berkin A, Szarek WA, Kisilevsky R. Synthesis and biological evaluation of a radiolabeled analog of methyl 2-acetamido-2,4-dideoxy-beta-D-xylo-hexopyranoside directed towards influencing cellular glycosaminoglycan biosynthesis. Carbohydrate Research. 337: 37-44. PMID 11755910  0.68
2000 Berkin A, Szarek WA, Kisilevsky R. Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose and their effects on cellular glycosaminoglycan biosynthesis. Carbohydrate Research. 326: 250-63. PMID 10890273  0.68
2000 Berkin A, Szarek MA, Plenkiewicz J, Szarek WA, Kisilevsky R. Synthesis of 4-deoxy analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-xylose and their effects on glycoconjugate biosynthesis. Carbohydrate Research. 325: 30-45. PMID 10741825  0.68
1996 Vaino AR, Chan SS, Szarek WA, Thatcher GR. An Experimental Reexamination of the Reverse Anomeric Effect in N-Glycosylimidazoles. The Journal of Organic Chemistry. 61: 4514-4515. PMID 11667373  1
1996 Inoue S, Hultin PG, Szarek WA, Kisilevsky R. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study. Laboratory Investigation; a Journal of Technical Methods and Pathology. 74: 1081-90. PMID 8667612  0.68
1995 Thomas SS, Plenkiewicz J, Ison ER, Bols M, Zou W, Szarek WA, Kisilevsky R. Influence of monosaccharide derivatives on liver cell glycosaminoglycan synthesis: 3-deoxy-D-xylo-hexose (3-deoxy-D-galactose) and methyl (methyl 4-chloro-4-deoxy-beta-D-galactopyranosid) uronate. Biochimica Et Biophysica Acta. 1272: 37-48. PMID 7662718  0.68
1995 Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG, Szarek WA. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nature Medicine. 1: 143-8. PMID 7585011  1
1994 Krebs A, Depew WT, Szarek WA, Hay GW, Hronowski LJ. Binding of D-galactose-terminated ligands to rabbit asialoglycoprotein receptor. Carbohydrate Research. 254: 257-68. PMID 8180988 DOI: 10.1016/0008-6215(94)84258-2  1
1994 Zou W, Szarek WA. An efficient conversion of D-mannitol into D-fructose and 1,5-dideoxy-1,5-imino-D-mannitol (1-deoxymannojirimycin). Carbohydrate Research. 254: 25-33. PMID 8180987 DOI: 10.1016/0008-6215(94)84240-X  1
1992 Hronowski LJ, Szarek WA, Hay GW, Krebs A, Depew WT. Synthesis and characterization of 6-O-beta-lactosyl-alpha,beta-lactoses, 1-O-(6-O-beta-lactosyl-beta-lactosyl)-(R,S)-glycerols, and 4,6-di-O-beta-D-galactopyranosyl-alpha,beta-D-glucoses. Carbohydrate Research. 226: 101-17. PMID 1499016 DOI: 10.1016/0008-6215(92)84058-Z  1
1992 Dow KE, Riopelle RJ, Szarek WA, Bols M, Ison ER, Plenkiewicz J, Lyon A, Kisilevsky R. Effects of 4-deoxy-L-threo-pentose, a novel carbohydrate, on neural cell proteoglycan synthesis and function. Biochimica Et Biophysica Acta. 1156: 7-14. PMID 1472541 DOI: 10.1016/0304-4165(92)90088-C  1
1991 Hronowski LJ, Szarek WA, Hay GW, Ison ER, Krebs A, Depew WT. Synthesis and characterization of 6-O-beta-lactosyl-alpha,beta-D-mannopyranoses and 2,6-di-O-beta-lactosyl-alpha,beta-D-mannopyranoses. Carbohydrate Research. 219: 51-69. PMID 1804537 DOI: 10.1016/0008-6215(91)89042-E  1
1991 Hronowski LJ, Szarek WA, Hay GW, Krebs A, Depew WT. Synthesis and characterization of 2-O-beta-lactosylglycerol, 1,2-di-O-beta-lactosyl-(R,S)-glycerols, and 1,2,3,-tri-O-beta-lactosylglycerol. Carbohydrate Research. 219: 33-49. PMID 1666539 DOI: 10.1016/0008-6215(91)89041-D  1
1984 Walton DJ, Ison ER, Szarek WA. Synthesis of N-(1-deoxyhexitol-1-yl)amino acids, reference compounds for the nonenzymic glycosylation of proteins. Carbohydrate Research. 128: 37-49. PMID 6733725 DOI: 10.1016/0008-6215(84)85082-X  1
1984 Walton DJ, Johnson AV, Szarek WA. Analysis of bound carbohydrates of human lens fractions by gas-liquid chromatography. Investigative Ophthalmology & Visual Science. 25: 774-6. PMID 6724849  1
1983 Iwakawa M, Martin OR, Szarek WA. Syntheses of 1-(5-deoxy-beta-D-arabino-hexofuranosyl)cytosine. Carbohydrate Research. 121: 99-108. PMID 6667470 DOI: 10.1016/0008-6215(83)84009-9  1
1983 Szarek WA, Stacey M, Hay GW. John Kenyon Netherton Jones (1912-1977). Advances in Carbohydrate Chemistry and Biochemistry. 41: 1-26. PMID 6356804 DOI: 10.1016/S0065-2318(08)60054-2  1
1982 Johnson AV, Szarek WA, Walton DJ. Carbohydrates of the bovine lens: analysis of bound hexoses and hexosamines of the plasma membrane and other fractions by gas-liquid chromatography. Experimental Eye Research. 35: 391-400. PMID 7140856 DOI: 10.1016/0014-4835(82)90103-8  1
1982 Dinda PK, Beck IT, Szarek WA, Hay GW, Ison ER, Vyas DM. Evidence that L-sucrose is resistant to hydrolysis catalyzed by jejunal brush border enzymes. Canadian Journal of Physiology and Pharmacology. 60: 652-4. PMID 7104853  1
1977 Schnarr GW, Szarek WA, Jones JK. Preparation and Activity of Immobilized Acetobacter suboxydans Cells. Applied and Environmental Microbiology. 33: 732-4. PMID 16345235  1
1977 Szarek WA, Schnarr GW. Oxidation of glycosides by Acetobacter suboxydans: synthesis of methyl alpha- and beta-L-threo-pentopyranosid-4-uloses. Carbohydrate Research. 55: C5-7. PMID 861970  1
1977 Szarek WA, Schnarr GW, Jarrell HC, Jones JK. Oxidation of a branched-chain alditol by acetobacter suboxydans: a stereospecific synthesis of L-dendroketose. Carbohydrate Research. 53: 101-8. PMID 844055  1
1977 Szarek WA. Professor J. K. N. Jones, F.R.S. Carbohydrate Research. 55: 1-2. PMID 324627  0.01
1976 Woolard GR, Rathbone EB, Szarek WA, Jones JK. Syntheses towards the carbohydrate moiety of lincomycin. Journal of the Chemical Society. Perkin Transactions 1. 950-4. PMID 944716  1
1971 Williams EH, Szarek WA, Jones JK. Preparation of unsaturated carbohydrates from methyl 4,6-O-benzylidene-3-chloro-3-deoxy- -D-allopyranoside, and their utility in the synthesis of sugars of biological importance. Carbohydrate Research. 20: 49-57. PMID 5151197  1
1970 Howarth GB, Szarek WA, Jones JK. The synthesis of lincomycin. Journal of the Chemical Society. Perkin Transactions 1. 16: 2218-24. PMID 5528931  1
1966 Wolfrom ML, Tomomatsu H, Szarek WA. Configuration of the glycosidic linkage of 2-amino-2-deoxy-D-glucopyranose to D-glucuronic acid in heparin. The Journal of Organic Chemistry. 31: 1173-8. PMID 5907870  1
Show low-probability matches.